drugset / Trial / NCT00905073

Low Dose Cyclosporin and Methotrexate Therapy in Diabetes

NCT00905073

Completed 8 enrolled Georgetown University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether treatment with low dose cyclosporin and methotrexate can inhibit the development of new onset diabetes mellitus

Timeline

Start
1990-02
Primary completion
1994-06
Completion
1994-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 4 mg/kg
Subject Methotrexate Small molecule 5 mg/kg